spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online 7 December 2004
doi: 10.1242/jcs.01562

Journal of Cell Science 118, 89-99 (2005)
Published by The Company of Biologists 2005
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jcs.01562v1
118/1/89    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JCS
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, A. J.
Right arrow Articles by Werstuck, G. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, A. J.
Right arrow Articles by Werstuck, G. H.

Research Article

Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3

Anna J. Kim1, Yuanyuan Shi2, Richard C. Austin2,3 and Geoff H. Werstuck1,2,4,*

1 Department of Biochemistry, McMaster University, Hamilton, Ontario, L8S 4LB, Canada
2 Henderson Research Centre, Hamilton, Ontario, L8V 1C3, Canada
3 Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, L8S 4LB, Canada
4 Department of Medicine, McMaster University, Hamilton, Ontario, L8S 4LB, Canada

* Author for correspondence (e-mail: gwerstuck{at}thrombosis.hhscr.org)

Accepted 24 September 2004

A wide range of agents and conditions are known to disrupt the ability of the endoplasmic reticulum (ER) to fold proteins properly, resulting in the onset of ER dysfunction/stress. We and others have shown that ER stress can induce intracellular lipid accumulation through the activation of the sterol responsive element binding proteins (SREBPs) and initiate programmed cell death by activation of caspases. It has been suggested that ER stress-induced lipid accumulation and cell death play a role in the pathogenesis of disorders including Alzheimer's disease, Parkinson's disease, type-1 diabetes mellitus and hepatic steatosis. Here we show that exposure of HepG2 cells to the branch chain fatty acid, valproate, increases cellular resistance to ER stress-induced dysfunction. Two distinctly different potential mechanisms for this protective effect were investigated. We show that exposure to valproate increases the expression of chaperones that assist in the folding of proteins in the ER including GRP78/BiP, GRP94, PDI and calreticulin as well as the cytosolic chaperone, HSP70. However, exposure of HepG2 cells to valproate does not decrease the apparent ER stress response in cells challenged with tunicamycin, A23187 or glucosamine, suggesting that valproate-conferred protection occurs downstream of ER dysfunction. Finally, we demonstrate that valproate directly inhibits the glycogen synthase kinases (GSK)-3{alpha}/ß. The ability of lithium, another inhibitor of GSK3{alpha}/ß to protect cells from ER stress-induced lipid accumulation suggests that GSK3 plays a central role in signaling downstream effects of ER stress. Strategies to protect cells from agents/conditions that induce ER stress may have potential in the treatment of the growing number of diseases and disorders linked to ER dysfunction.

Key words: Valproate, Endoplasmic reticulum stress, Apoptosis, Lipid accumulation, Glycogen synthase kinase


Related articles in JCS:

ER stress relief

JCS 2005 118: 101. [Full Text]  



This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
J.-C. Chen, M.-L. Wu, K.-C. Huang, and W.-W. Lin
HMG-CoA reductase inhibitors activate the unfolded protein response and induce cytoprotective GRP78 expression
Cardiovasc Res, October 1, 2008; 80(1): 138 - 150.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Gong, A. Rifai, Y. Ge, S. Chen, and L. D. Dworkin
Hepatocyte Growth Factor Suppresses Proinflammatory NF{kappa}B Activation through GSK3{beta} Inactivation in Renal Tubular Epithelial Cells
J. Biol. Chem., March 21, 2008; 283(12): 7401 - 7410.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
Y. Leng, M.-H. Liang, M. Ren, Z. Marinova, P. Leeds, and D.-M. Chuang
Synergistic Neuroprotective Effects of Lithium and Valproic Acid or Other Histone Deacetylase Inhibitors in Neurons: Roles of Glycogen Synthase Kinase-3 Inhibition
J. Neurosci., March 5, 2008; 28(10): 2576 - 2588.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
G. Kroemer, L. Galluzzi, and C. Brenner
Mitochondrial Membrane Permeabilization in Cell Death
Physiol Rev, January 1, 2007; 87(1): 99 - 163.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M.-J. Boucher, L. Selander, L. Carlsson, and H. Edlund
Phosphorylation Marks IPF1/PDX1 Protein for Degradation by Glycogen Synthase Kinase 3-dependent Mechanisms
J. Biol. Chem., March 10, 2006; 281(10): 6395 - 6403.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
G. H. Werstuck, M. I. Khan, G. Femia, A. J. Kim, V. Tedesco, B. Trigatti, and Y. Shi
Glucosamine-Induced Endoplasmic Reticulum Dysfunction Is Associated With Accelerated Atherosclerosis in a Hyperglycemic Mouse Model
Diabetes, January 1, 2006; 55(1): 93 - 101.
[Abstract] [Full Text] [PDF]


© The Company of Biologists Ltd 2005